Precision treatment for multiple sclerosis: Maximising the effect of immunomodulatory therapy [ 2017 - 2021 ]

Research Grant

Researchers: Prof Helmut Butzkueven

Brief description Response to therapy varies greatly among patients with multiple sclerosis (MS). The current lack of individualised MS therapy may lead to suboptimal MS management and accumulation of preventable disability. We will use MSBase, a large international MS cohort, to evaluate the effect of different treatment strategies and of highly effective and novel therapies. Identifying the patients who will benefit from these therapies, we will provide the key evidence for individualised MS management.

Funding Amount $AUD 551,868.79

Funding Scheme Project Grants

Notes Standard Project Grant